1,3-Bis(aryloxy)propan-2-ols as potential antileishmanial agents.

about

1,3-Bis(aryloxy)propan-2-ols as potential antileishmanial agents.

Item

http://www.wikidata.org/entity/Q38673741

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

1,3-Bis(aryloxy)propan-2-ols as potential antileishmanial agents.

@en

type

Item

label

1,3-Bis(aryloxy)propan-2-ols as potential antileishmanial agents.

@en

prefLabel

1,3-Bis(aryloxy)propan-2-ols as potential antileishmanial agents.

@en

P1476

1,3-Bis(aryloxy)propan-2-ols as potential antileishmanial agents

@en

P2093

Carlos A P Tavares

http://www.w3.org/2001/XMLSchema#string

Daniela P Lage

http://www.w3.org/2001/XMLSchema#string

Eduardo A F Coelho

http://www.w3.org/2001/XMLSchema#string

Mariana C Duarte

http://www.w3.org/2001/XMLSchema#string

Stefânia N Lavorato

http://www.w3.org/2001/XMLSchema#string

P2860

Advances in Development of New Treatment for Leishmaniasis

Adrenergic agents. 4. Substituted phenoxypropanolamine derivatives as potential beta-adrenergic agonists

Lipophilicity--methods of determination and its role in medicinal chemistry.

An update on pharmacotherapy for leishmaniasis

Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.

Evaluation of macroalgae sulfated polysaccharides on the Leishmania (L.) amazonensis promastigote.

Biological evaluation of bisbenzaldehydes against four Mycobacterium species.

Fragment-based design of symmetrical bis-benzimidazoles as selective inhibitors of the trimethoprim-resistant, type II R67 dihydrofolate reductase.

In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.

P304

981-986

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CBDD.13024

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ricardo J Alves

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28590516

http://www.w3.org/2001/XMLSchema#string

P932

5697679

http://www.w3.org/2001/XMLSchema#string